IN THIS issue of the ARCHIVES, 2 studies offer quite different perspectives on indoor tanning. Carlin et al1 report on the combination of acitretin and commercial tanning beds as an effective and useful therapy for psoriasis in geographic areas without access to physician-directed phototherapy. At the University of Utah Health Sciences Center, 26 patients with psoriasis who attended dermatology clinics were retrospectively surveyed in regard to treatments with acitretin and tanning bed light. Of 26 patients with moderate to severe plaque-type psoriasis, 23 received a follow-up physical examination. Nineteen (83%) of 23 experienced either clearance or new clearance of their psoriasis. The authors also conducted a small prospective study in 17 patients with moderate to severe plaque-type psoriasis. Patients received 25 mg of acitretin per day and 5 to 7 tanning sessions per week for 12 weeks. Of 14 patients who completed the study, Psoriasis Area and Severity Index and National Psoriasis Foundation scores decreased on average 78.6% and 79%, respectively, from baseline. Adverse events were generally mild to moderate.
Demierre M. Time for the National Legislation of Indoor Tanning to Protect Minors. Arch Dermatol. 2003;139(4):520–524. doi:10.1001/archderm.139.4.520
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.